News
A new clinical trial conducted by researchers at the Medical University of Silesia in Katowice found that topical cannabidiol ...
FDA grants fast track designation to CLD-201, an innovative therapy for soft tissue sarcoma, enhancing its development and ...
In an extension trial, apremilast showed sustained clinical benefit and a consistent safety profile in children and ...
Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...
Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion ...
Patient treated at Clinica la Sagrada Familia in Buenos Aires, Argentina BOSTON, July 30, 2025 /PRNewswire/ -- CereVasc, Inc.
Strategic IP expansion protects federated learning technology driving pharma partnerships, biosecurity initiatives, and ...
This IND clearance represents a major milestone for EuMentis as we advance EM–221 through Phase 2 clinical development,” said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results